Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Shares of Charter Communications, Inc. (NASDAQ:CHTR) rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and revenues.
Charter Communications, Inc.(纳斯达克股票代码:CHTR)的股价在今天的盘前交易中大幅上涨,此前该公司公布的第三季度每股收益和收入好于预期。
Charter Communications reported fiscal third-quarter 2024 revenue growth of 1.6% year-on-year to $13.8 billion, beating the analyst consensus estimate of $13.7 billion. EPS of $8.82 beat the analyst consensus estimate of $8.67
Charter Communications报告称,2024财年第三季度收入同比增长1.6%,达到138亿美元,超过了分析师共识估计的137亿美元。每股收益为8.82美元,超过了分析师共识预期的8.67美元
Charter Communications shares rose 11.1% to $364.01 in the pre-market trading session.
Charter Communications股价在盘前交易时段上涨11.1%,至364.01美元。
Here are some other stocks moving in pre-market trading.
以下是盘前交易中其他一些股票。
Gainers
获胜者
- Globalstar, Inc (NYSE:GSAT) gained 41.9% to $1.49 in pre-market trading after the company announced a proposed public offering.
- Theriva Biologics, Inc. (NYSE:TOVX) rose 41.1% to $2.06 in pre-market trading after the company announced it was selected as a finalist for Merck KGaA's EMEA Advance Biotech Grant.
- Athira Pharma, Inc. (NASDAQ:ATHA) shares surged 31.1% to $0.5610 in pre-market trading.
- VS MEDIA Holdings Limited (NASDAQ:VSME) climbed 30% to $1.43 in pre-market trading after declining 11% on Thursday.
- Atlassian Corporation (NASDAQ:TEAM) gained 22.5% to $231.06 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.
- Nuburu, Inc. (NYSE:BURU) gained 18.6% to $0.5340 in pre-market trading.
- Proto Labs, Inc. (NYSE:PRLB) gained 18.3% to $32.43 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance with its midpoint above estimates.
- comScore, Inc. (NASDAQ:SCOR) shares rose 17.3% to $6.45 in pre-market trading.
- Halozyme Therapeutics, Inc. (NASDAQ:HALO) gained 12.8% to $57.04 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY24 adjusted EPS guidance above estimates.
- 全球之星公司(纽约证券交易所代码:GSAT)宣布拟议的公开募股后,该公司在盘前交易中上涨41.9%,至1.49美元。
- Theriva Biologics, Inc.(纽约证券交易所代码:TOVX)在盘前交易中上涨41.1%,至2.06美元,此前该公司宣布入选默沙东KGaA的欧洲、中东和非洲高级生物技术补助金的决赛入围者。
- Athira Pharma, Inc.(纳斯达克股票代码:ATHA)股价在盘前交易中飙升31.1%,至0.5610美元。
- VS MEDIA Holdings Limited(纳斯达克股票代码:VSME)在周四下跌11%后,在盘前交易中上涨了30%,至1.43美元。
- Atlassian Corporation(纳斯达克股票代码:TEAM)在盘前交易中上涨22.5%,至231.06美元,此前该公司公布的第一季度财务业绩好于预期,并发布了高于预期的第二季度收入指引。
- Nuburu, Inc.(纽约证券交易所代码:BURU)在盘前交易中上涨18.6%,至0.5340美元。
- Proto Labs, Inc.(纽约证券交易所代码:PRLB)在盘前交易中上涨18.3%,至32.43美元,此前该公司公布的第三季度财务业绩好于预期,并发布了中点高于预期的第四季度调整后每股收益指引。
- comScore, Inc.(纳斯达克股票代码:SCOR)股价在盘前交易中上涨17.3%,至6.45美元。
- Halozyme Therapeutics, Inc.(纳斯达克股票代码:HALO)在盘前交易中上涨12.8%,至57.04美元,此前该公司公布的第三季度财务业绩好于预期,并发布了高于预期的24财年调整后每股收益指引。
Losers
失败者
- ESSA Pharma Inc. (NASDAQ:EPIX) shares dipped 69.2% to $1.60 in pre-market trading. ESSA Pharma terminated Phase 2 study evaluating Masofaniten combined with Enzalutamide in patients with mCRPC.
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) fell 37.4% to $1.2207 in pre-market trading.
- Elevai Labs Inc. (NASDAQ:ELAB) fell 35% to $0.0383 in pre-market trading.
- MultiMetaVerse Holdings Limited (NASDAQ:MMV) declined 24.1% to $0.3331 in pre-market trading.
- Arbe Robotics Ltd. (NASDAQ:ARBE) declined 18.7% to $1.4800 in pre-market trading after the company announced a public offering.
- Advent Technologies Holdings, Inc. (NYSE:ADN) fell 15.8% to $1.9899 in pre-market trading after jumping around 34% on Thursday.
- ASP Isotopes Inc. (NASDAQ:ASPI) fell 8.4% to $6.40 in pre-market trading after the company announced a proposed public offering.
- BJ's Restaurants, Inc. (NASDAQ:BJRI) fell 6.3% to $34.75 in today's pre-market trading after the company announced worse-than-expected third-quarter EPS results.
- nVent Electric plc (NYSE:NVT) shares fell 6.1% to $70.00 in pre-market trading after the company reported third-quarter results.
- DigitalBridge Group, Inc. (NASDAQ:DBRG) declined 6% to $14.75 in pre-market trading after the company reported weaker-than-expected third-quarter results.
- ESSA制药公司(纳斯达克股票代码:EPIX)股价在盘前交易中下跌69.2%,至1.60美元。ESSA Pharma终止了评估Masofaniten与恩扎鲁胺联合用于mcRPC患者的2期研究。
- Lexicon Pharmicals, Inc.(纳斯达克股票代码:LXRX)在盘前交易中下跌37.4%,至1.2207美元。
- Elevai Labs Inc.(纳斯达克股票代码:ELAB)在盘前交易中下跌35%,至0.0383美元。
- 多元界控股有限公司(纳斯达克股票代码:MMV)在盘前交易中下跌24.1%,至0.3331美元。
- Arbe Robotics Ltd.(纳斯达克股票代码:ARBE)宣布公开募股后,该公司在盘前交易中下跌18.7%,至1.4800美元。
- Advent Technologies Holdings, Inc.(纽约证券交易所代码:ADN)在周四上涨约34%后,在盘前交易中下跌15.8%,至1.9899美元。
- ASP同位素公司(纳斯达克股票代码:ASPI)宣布拟议公开募股后,在盘前交易中下跌8.4%,至6.40美元。
- BJ's Restaurants, Inc.(纳斯达克股票代码:BJRI)在今天的盘前交易中下跌6.3%,至34.75美元,此前该公司公布的第三季度每股收益低于预期。
- nVent Electric plc(纽约证券交易所代码:NVT)公布第三季度业绩后,股价在盘前交易中下跌6.1%,至70.00美元。
- DigitalBridge集团公司(纳斯达克股票代码:DBRG)在盘前交易中下跌6%,至14.75美元,此前该公司公布的第三季度业绩低于预期。
Now Read This:
现在读这个:
- S&P 500 Records Worst Session In Over A Month, Meta And Microsoft Tumble: Greed Index Moves To 'Fear' Zone
- 标普500指数创下一个多月来最差交易日,Meta和微软暴跌:贪婪指数转向 “恐惧” 区域